back to Australia directory
australia clinical guidance

HIV testing in primary care (who, when, and how to interpret results)

A detailed Australian summary of hiv testing in primary care (who, when, and how to interpret results), with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Offer HIV testing routinely when clinically indicated and normalize opt-out discussion, obtaining informed consent without exceptional written procedures. Test after sexual or injecting exposure, STI, indicator condition, pregnancy or patient request using the National HIV Testing Policy algorithm. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:National HIV Testing Policy

The Bottom Line

  • Offer HIV testing routinely when clinically indicated and normalize opt-out discussion, obtaining informed consent without exceptional written procedures.
  • Test after sexual or injecting exposure, STI, indicator condition, pregnancy or patient request using the National HIV Testing Policy algorithm.
  • A fourth-generation laboratory assay shortens but does not eliminate the window after recent exposure, so schedule repeat testing precisely.
  • Account for the diagnostic window and recent PEP or PrEP; repeat testing or nucleic-acid testing may be needed after very recent exposure.
sources for this section:National HIV Testing Policy

Practical clinical workflow

1

Topic-specific assessment action

Offer HIV testing routinely when clinically indicated and normalize opt-out discussion, obtaining informed consent without exceptional written procedures.
2

Topic-specific diagnostic action

Account for the diagnostic window and recent PEP or PrEP; repeat testing or nucleic-acid testing may be needed after very recent exposure.
3

Topic-specific management action

A reactive screening result is preliminary: arrange confirmatory laboratory testing, provide support and protect confidentiality without labelling a diagnosis prematurely.
4

Topic-specific follow-through

Acute HIV may present with fever, rash, pharyngitis and lymphadenopathy and requires antigen or RNA-aware urgent testing.
sources for this section:National HIV Testing Policy

Safety boundaries and escalation

  • For a new confirmed diagnosis, arrange prompt specialist linkage, baseline assessment, partner-notification support and immediate evaluation of acute severe illness.
  • Offer testing privately and avoid disclosure through billing, messaging or family contact without consent.
sources for this section:National HIV Testing Policy

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:National HIV Testing Policy

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:National HIV Testing Policy

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Australasian Society for HIV, Viral Hepatitis and Sexual Health MedicineNational HIV Testing Policy2023 policy 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.